{"id":"vasopressin-administration","safety":{"commonSideEffects":[{"rate":"50-70%","effect":"Hypertension"},{"rate":"20-40%","effect":"Nausea"},{"rate":"10-30%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1201528","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to increased blood pressure and improved perfusion of vital organs. Vasopressin also has antidiuretic effects by stimulating V2 receptors in the kidneys, reducing water loss in the urine.","oneSentence":"Vasopressin acts as a potent vasoconstrictor by stimulating V1A receptors on vascular smooth muscle cells, causing blood vessels to constrict.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:15.047Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemorrhagic shock"},{"name":"Cardiogenic shock"},{"name":"Severe burns"}]},"trialDetails":[{"nctId":"NCT04569591","phase":"NA","title":"DDAVP for Pituitary Adenoma","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2026-03-09","conditions":"Cushing's Disease, Pituitary Adenoma","enrollment":22},{"nctId":"NCT06337838","phase":"PHASE3","title":"Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-09","conditions":"Chronic Kidney Diseases, Acute Kidney Injury, Bleeding","enrollment":100},{"nctId":"NCT07292753","phase":"NA","title":"Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-12-15","conditions":"Nocturnal Enuresis, Vitamin D Deficiency","enrollment":90},{"nctId":"NCT05958342","phase":"PHASE2","title":"CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial","status":"RECRUITING","sponsor":"Jason Sperry","startDate":"2024-06-30","conditions":"Trauma, Hemorrhage","enrollment":1050},{"nctId":"NCT07460908","phase":"NA","title":"Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome","status":"COMPLETED","sponsor":"Lahore General Hospital","startDate":"2025-05-01","conditions":"Hepatorenal Syndrome","enrollment":60},{"nctId":"NCT07446933","phase":"PHASE2","title":"Vasopressin vs. Uterine Artery Clamping for Laparoscopic Cesarean Scar Niche Repair","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2024-03-20","conditions":"Cesarean Section Complications","enrollment":30},{"nctId":"NCT07438925","phase":"","title":"Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2025-12-22","conditions":"Hemodialysis","enrollment":71},{"nctId":"NCT05824767","phase":"PHASE4","title":"Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2023-04-17","conditions":"Septic Shock, Vasodilatory Shock","enrollment":40},{"nctId":"NCT05190744","phase":"PHASE2","title":"Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-09-01","conditions":"Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus","enrollment":36},{"nctId":"NCT07063680","phase":"PHASE3","title":"Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2026-01","conditions":"Patients With Norepinephrine-refractory Vasoplegic Shock","enrollment":390},{"nctId":"NCT06771128","phase":"NA","title":"Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-11-01","conditions":"Nocturnal Enuresis in Children, Desmopressin, Monosymptomatic Nocturnal Enuresis","enrollment":398},{"nctId":"NCT02118467","phase":"PHASE4","title":"Vasoactive Drugs in Intensive Care Unit","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2014-05-15","conditions":"Shock","enrollment":836},{"nctId":"NCT07328529","phase":"PHASE2","title":"Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Azevan Pharmaceuticals","startDate":"2026-03","conditions":"Aggressive Behavior in Fragile X Syndome","enrollment":80},{"nctId":"NCT06036004","phase":"PHASE2","title":"Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-01-08","conditions":"Central Diabetes Insipidus (cDI)","enrollment":112},{"nctId":"NCT05568160","phase":"PHASE3","title":"Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2023-01-02","conditions":"Scheduled Cardiac Surgery With Extracorporeal Circulation, Vasoplegic Syndrome","enrollment":840},{"nctId":"NCT07286643","phase":"NA","title":"Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2026-01-01","conditions":"Cirrhosis, Liver, Cirrhotic Cardiomyopathy, Septic Shock","enrollment":140},{"nctId":"NCT07255378","phase":"","title":"Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication","status":"RECRUITING","sponsor":"Jamil Cedeño Mora","startDate":"2025-10-01","conditions":"Septic Shock","enrollment":1200},{"nctId":"NCT06161766","phase":"","title":"Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease","status":"COMPLETED","sponsor":"University Hospital Freiburg","startDate":"2024-03-03","conditions":"Liver Cirrhosis, Hepato-Renal Syndrome, Chronic Kidney Diseases","enrollment":490},{"nctId":"NCT07252401","phase":"NA","title":"Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Gastrointestinal Bleeding and Acute Kidney Injury","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-12-25","conditions":"Liver Cirrhosis","enrollment":64},{"nctId":"NCT06203847","phase":"NA","title":"The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2024-07-16","conditions":"Cardiac Arrest, Out-Of-Hospital Cardiac Arrest, Emergency Medical Services","enrollment":1344},{"nctId":"NCT07102615","phase":"PHASE4","title":"Intracervical Vasopressin","status":"RECRUITING","sponsor":"Prisma Health-Upstate","startDate":"2025-10-30","conditions":"Retained Products of Conception","enrollment":50},{"nctId":"NCT06217562","phase":"PHASE4","title":"Vasopressin for Septic Shock Pragmatic Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Intermountain Health Care, Inc.","startDate":"2024-02-01","conditions":"Septic Shock","enrollment":2050},{"nctId":"NCT06605300","phase":"NA","title":"The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-10-02","conditions":"Healthy","enrollment":120},{"nctId":"NCT06808516","phase":"PHASE2","title":"Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-07-01","conditions":"Arginine Vasopressin Deficiency, Central Diabetes Insipidus, Oxytocin Deficiency","enrollment":42},{"nctId":"NCT07199894","phase":"PHASE3","title":"Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-12-01","conditions":"Nocturnal Enuresis in Children","enrollment":120},{"nctId":"NCT03204786","phase":"PHASE2, PHASE3","title":"Intranasal Vasopressin Treatment in Children With Autism","status":"COMPLETED","sponsor":"Stanford University","startDate":"2018-02-20","conditions":"Autism, Autism Spectrum Disorder, ASD","enrollment":157},{"nctId":"NCT06361693","phase":"","title":"Descriptive Observational Study of Patient-performed Pre-oxygenation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-10-14","conditions":"Anesthesia, ASA Physical Status I, ASA Physical Status II","enrollment":110},{"nctId":"NCT04592744","phase":"PHASE4","title":"Angiotensin 2 for AKI After OLT","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Los Angeles","startDate":"2022-04-08","conditions":"Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury","enrollment":30},{"nctId":"NCT07052084","phase":"PHASE3","title":"Systematic Adjunction of Vasopressine in Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2026-01","conditions":"Septic Shock","enrollment":120},{"nctId":"NCT06155812","phase":"PHASE2, PHASE3","title":"Multimodal Vasopressor Strategy in Septic Shock","status":"RECRUITING","sponsor":"University Medical Centre Maribor","startDate":"2023-12-23","conditions":"Shock, Septic","enrollment":80},{"nctId":"NCT04591990","phase":"PHASE3","title":"HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-05-27","conditions":"Postresuscitation Syndrome","enrollment":380},{"nctId":"NCT06020495","phase":"PHASE3","title":"Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-12-17","conditions":"Hyponatremia","enrollment":260},{"nctId":"NCT03446456","phase":"PHASE1, PHASE2","title":"Vasopressin and Pain Perception in the Brain","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2018-09-17","conditions":"Acute Pain","enrollment":40},{"nctId":"NCT06547892","phase":"PHASE2","title":"Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-04-10","conditions":"Critical Illness","enrollment":60},{"nctId":"NCT04501861","phase":"PHASE3","title":"Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2020-11-05","conditions":"Cardiac Disease","enrollment":153},{"nctId":"NCT06855758","phase":"NA","title":"Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2025-03-06","conditions":"Kidney Transplant, Delayed Graft Function, Intraoperative Hypotension","enrollment":150},{"nctId":"NCT05293041","phase":"PHASE4","title":"Argipressin's Influence on Blood Loss During Hepatic Resection","status":"COMPLETED","sponsor":"Kristina Svennerholm","startDate":"2022-03-27","conditions":"Colon Cancer Liver Metastasis, Inflammatory Response, Vasopressin Causing Adverse Effects in Therapeutic Use","enrollment":248},{"nctId":"NCT06853574","phase":"NA","title":"Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"General and Teaching Hospital Celje","startDate":"2025-02","conditions":"Sepsis, Septic Shock","enrollment":30},{"nctId":"NCT06789705","phase":"NA","title":"Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-01-27","conditions":"Central Diabetes Insipidus","enrollment":24},{"nctId":"NCT06460948","phase":"EARLY_PHASE1","title":"Identifying Oxytocin Deficiency in Adults With Pituitary Disease","status":"RECRUITING","sponsor":"Elizabeth Austen Lawson","startDate":"2024-11-13","conditions":"Arginine Vasopressin Deficiency, Oxytocin Deficiency","enrollment":32},{"nctId":"NCT06419075","phase":"PHASE4","title":"Tranexamic Acid in Vaginal Reconstructive Surgery","status":"WITHDRAWN","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2024-07-01","conditions":"Pelvic Organ Prolapse","enrollment":""},{"nctId":"NCT06256432","phase":"PHASE2","title":"Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome","status":"RECRUITING","sponsor":"Noorik Biopharmaceuticals AG","startDate":"2024-04-17","conditions":"Hepatorenal Syndrome, Liver Cirrhosis, Acute Kidney Injury","enrollment":54},{"nctId":"NCT06772584","phase":"NA","title":"Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-01-01","conditions":"Enuresis, Nocturnal","enrollment":90},{"nctId":"NCT04329975","phase":"","title":"Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2020-05-19","conditions":"Nocturia Due to Nocturnal Polyuria","enrollment":1087},{"nctId":"NCT05346393","phase":"NA","title":"HRS-AKI Treatment With TIPS in Patients With Cirrhosis","status":"RECRUITING","sponsor":"Jena University Hospital","startDate":"2022-11-29","conditions":"Cirrhosis, Liver, Hepatorenal Syndrome, Acute Kidney Injury","enrollment":124},{"nctId":"NCT06471231","phase":"PHASE4","title":"Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock","status":"RECRUITING","sponsor":"Azienda Usl di Bologna","startDate":"2024-05-15","conditions":"Septic Shock, Renal Function Replacement","enrollment":264},{"nctId":"NCT04420585","phase":"PHASE4","title":"Desmopressin for Bedwetting in Children With SCD","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2020-07-07","conditions":"Nocturnal Enuresis, Anemia, Sickle Cell","enrollment":8},{"nctId":"NCT04961528","phase":"PHASE3","title":"ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-03-27","conditions":"Hemoptysis","enrollment":315},{"nctId":"NCT06376318","phase":"","title":"Shock and Acute Conditions OutcOmes Platform","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saint-Louis Hospital, Paris, France","startDate":"2024-01-01","conditions":"Circulatory Shock, Sepsis, Cardiogenic Shock","enrollment":1000},{"nctId":"NCT06329063","phase":"NA","title":"Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT06329037","phase":"NA","title":"The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT05193370","phase":"PHASE4","title":"Angiotensin II vs. Vasopressin in Septic Shock","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2022-01-03","conditions":"Septic Shock","enrollment":""},{"nctId":"NCT06302998","phase":"PHASE2","title":"Dexmedetomidine and Vasopressin in Septic Shock","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2024-06","conditions":"Sepsis, Septic Shock","enrollment":260},{"nctId":"NCT06265259","phase":"PHASE4","title":"Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients","status":"RECRUITING","sponsor":"University of Thessaly","startDate":"2023-12-15","conditions":"Circulatory Shock","enrollment":145},{"nctId":"NCT03130127","phase":"NA","title":"Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis","status":"UNKNOWN","sponsor":"General Hospital of Shenyang Military Region","startDate":"2024-07-01","conditions":"Liver Cirrhosis, Portal Hypertension, Variceal Hemorrhage","enrollment":40},{"nctId":"NCT06268587","phase":"","title":"A Before and After Study Studying the Impact of an Analgesia Protocol After Discharge From Outpatient Surgery","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Liege","startDate":"2019-09-01","conditions":"Postoperative Pain, Outpatient Surgery","enrollment":1423},{"nctId":"NCT06185361","phase":"NA","title":"Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.","status":"UNKNOWN","sponsor":"Fayoum University Hospital","startDate":"2022-12-01","conditions":"Nocturnal Enuresis, Enuresis, Enuresis, Nocturnal","enrollment":60},{"nctId":"NCT05875948","phase":"PHASE2","title":"Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome","status":"UNKNOWN","sponsor":"River 2 Renal Corp.","startDate":"2023-06-30","conditions":"Hepatorenal Syndrome, Acute Kidney Injury","enrollment":95},{"nctId":"NCT04890470","phase":"NA","title":"Effects of Oxytocin and Vasopressin on Moral Decision Making","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2021-03-02","conditions":"Healthy","enrollment":180},{"nctId":"NCT06027970","phase":"PHASE3","title":"Efficacy of Continuous Terlipressin Therapy After Endoscopic Variceal Ligation","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2023-09","conditions":"Variceal Hemorrhage","enrollment":165},{"nctId":"NCT05617664","phase":"NA","title":"Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis","status":"UNKNOWN","sponsor":"Benha University","startDate":"2022-11-23","conditions":"Nocturnal Enuresis","enrollment":150},{"nctId":"NCT03389412","phase":"PHASE4","title":"The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2017-10-01","conditions":"Enuresis, Nocturnal","enrollment":324},{"nctId":"NCT05945420","phase":"PHASE4","title":"Adding Desmopressin to Tamsulosin for Treatment of BPH","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2023-07-20","conditions":"Nocturnal Polyurea in Patients With BPH","enrollment":160},{"nctId":"NCT03822091","phase":"PHASE3","title":"Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-01-28","conditions":"Type 1 HEPATO RENAL SYNDROME(HRS)","enrollment":60},{"nctId":"NCT05207280","phase":"PHASE3","title":"Clinical Trial Comparing Noradrenaline (NA) Plus Placebo Versus Noradrenaline Plus Terlipressin (TP) in Septic Shock","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-10-11","conditions":"Septic Shock","enrollment":152},{"nctId":"NCT03636451","phase":"PHASE3","title":"Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2018-10-29","conditions":"Abortion, Spontaneous, Abortion in First Trimester, Pain Uterus","enrollment":114},{"nctId":"NCT04416282","phase":"NA","title":"Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-06-22","conditions":"Acute-On-Chronic Liver Failure, Hepatorenal Syndrome, Acute Kidney Injury","enrollment":70},{"nctId":"NCT04064346","phase":"PHASE3","title":"Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease","status":"TERMINATED","sponsor":"Palladio Biosciences","startDate":"2021-10-28","conditions":"Autosomal Dominant Polycystic Kidney, ADPKD","enrollment":12},{"nctId":"NCT05674084","phase":"","title":"Vasopressor Support, Mean Arterial Pressure and Capillary Refill Time in Critically Ill Patients","status":"UNKNOWN","sponsor":"Medical University of Silesia","startDate":"2022-12-03","conditions":"Critical Illness","enrollment":150},{"nctId":"NCT01439997","phase":"PHASE4","title":"Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2012-03-26","conditions":"Nocturia","enrollment":5},{"nctId":"NCT05628558","phase":"","title":"Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A","status":"UNKNOWN","sponsor":"Groupe Maladies hémorragiques de Bretagne","startDate":"2020-07-01","conditions":"Hemophilia A, Mild, Desmopressin, Factor VIII","enrollment":800},{"nctId":"NCT05439460","phase":"PHASE4","title":"Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Stanford University","startDate":"2012-01","conditions":"Pulmonary Arterial Hypertension","enrollment":15},{"nctId":"NCT04089072","phase":"PHASE2","title":"Methylene Blue as a Third-line Vasopressor in Septic Shock","status":"UNKNOWN","sponsor":"Carilion Clinic","startDate":"2019-12-01","conditions":"Septic Shock","enrollment":250},{"nctId":"NCT04648137","phase":"NA","title":"Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-02-05","conditions":"Diabetes Insipidus","enrollment":30},{"nctId":"NCT05307042","phase":"","title":"Decline in Renal Concentration Ability in Lithium Treated Patients","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2022-05","conditions":"Lithium Toxicities, Bipolar Disorder, Concentration Ability Impaired","enrollment":51},{"nctId":"NCT03201419","phase":"PHASE2","title":"A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-07-27","conditions":"Nocturia","enrollment":302},{"nctId":"NCT05139849","phase":"PHASE3","title":"VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial","status":"RECRUITING","sponsor":"Tiohundra AB","startDate":"2021-11-17","conditions":"Cardiac Arrest;In-hospital Cardiac Arrest; Methylprednisolone; Vasopressin; Adrenaline; Randomized Clinical Trial","enrollment":1276},{"nctId":"NCT04819568","phase":"NA","title":"Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-06-25","conditions":"Liver Cirrhosis","enrollment":310},{"nctId":"NCT02733614","phase":"PHASE2","title":"Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD","status":"TERMINATED","sponsor":"Azevan Pharmaceuticals","startDate":"2016-12","conditions":"PTSD","enrollment":33},{"nctId":"NCT05080543","phase":"PHASE1","title":"Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients","status":"UNKNOWN","sponsor":"Amany Mousa Salama Muhammed","startDate":"2021-10","conditions":"Septic Shock","enrollment":36},{"nctId":"NCT04991259","phase":"NA","title":"To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-08-10","conditions":"Acute Liver Failure","enrollment":60},{"nctId":"NCT03107091","phase":"PHASE2","title":"Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites","status":"COMPLETED","sponsor":"BioVie Inc.","startDate":"2017-07-15","conditions":"Cirrhosis, Ascites Hepatic","enrollment":6},{"nctId":"NCT04715737","phase":"NA","title":"Differential Effects of Vasopressin and Oxytocin on Attention Control","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2017-12-19","conditions":"Healthy","enrollment":160},{"nctId":"NCT04493554","phase":"NA","title":"The Effects of Vasopressin on Attention Control","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2020-07-28","conditions":"Healthy","enrollment":89},{"nctId":"NCT03917758","phase":"NA","title":"Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors","status":"UNKNOWN","sponsor":"University of Turin, Italy","startDate":"2018-10-10","conditions":"Diabetes Mellitus, Type 2, Arterial Hypertension, Body Weight Changes","enrollment":30},{"nctId":"NCT04545931","phase":"PHASE4","title":"Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-15","conditions":"Primary Monosymptomatic Nocturnal Enuresis","enrollment":80},{"nctId":"NCT02959411","phase":"PHASE4","title":"Tolvaptan for Advanced or Refractory Heart Failure","status":"TERMINATED","sponsor":"University of Calgary","startDate":"2016-10","conditions":"Heart Failure, Hyponatremia","enrollment":9},{"nctId":"NCT03088345","phase":"PHASE2, PHASE3","title":"Early Use of Vasopressin in Post-Fontan Management","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2017-03-06","conditions":"Circulatory Perfusion Disorder, Congenital Heart Disease, Single-ventricle","enrollment":20},{"nctId":"NCT04221672","phase":"PHASE3","title":"The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2019-11-07","conditions":"Terlipressin Adverse Reaction, Ascites Hepatic, Liver Failure","enrollment":86},{"nctId":"NCT04190004","phase":"NA","title":"Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia","status":"COMPLETED","sponsor":"National Institute of Mental Health and Neuro Sciences, India","startDate":"2018-01-01","conditions":"Schizophrenia","enrollment":30},{"nctId":"NCT02718079","phase":"NA","title":"High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-12-30","conditions":"Acute Liver Failure","enrollment":40},{"nctId":"NCT02090829","phase":"PHASE2","title":"Intranasal Oxytocin and Learning in Autism","status":"WITHDRAWN","sponsor":"University of Minnesota","startDate":"2014-03","conditions":"Autism Spectrum Disorders","enrollment":""},{"nctId":"NCT04119206","phase":"","title":"Tolvaptan Versus Fluid Restriction in SIADH","status":"COMPLETED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2009-01-01","conditions":"Hyponatremia, Syndrome of Inappropriate ADH (SIADH) Secretion, Pituitary","enrollment":334},{"nctId":"NCT04113005","phase":"EARLY_PHASE1","title":"Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer","status":"UNKNOWN","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2019-10-01","conditions":"Castrate Resistance Prostate Cancer","enrollment":10},{"nctId":"NCT04110418","phase":"PHASE2","title":"Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-02-19","conditions":"Neonatal Sepsis, Refractory Shock","enrollment":36},{"nctId":"NCT02905682","phase":"PHASE3","title":"Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-09","conditions":"Nocturia","enrollment":190},{"nctId":"NCT02904759","phase":"PHASE3","title":"Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-09","conditions":"Nocturia","enrollment":342},{"nctId":"NCT00624650","phase":"PHASE2","title":"Hemodynamics and Extravascular Lung Water in Acute Lung Injury","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2008-02","conditions":"Acute Lung Injury","enrollment":33},{"nctId":"NCT01962870","phase":"PHASE2","title":"The Role of Vasopressin in the Social Deficits of Autism","status":"COMPLETED","sponsor":"Stanford University","startDate":"2013-12","conditions":"Autism Spectrum Disorders","enrollment":68},{"nctId":"NCT02726620","phase":"NA","title":"Decision Support for Intraoperative Low Blood Pressure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-01-05","conditions":"Hypotension","enrollment":22435}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Vasopressin administration","genericName":"Vasopressin administration","companyName":"Assistance Publique Hopitaux De Marseille","companyId":"assistance-publique-hopitaux-de-marseille","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vasopressin, a vasopressin V2 receptor agonist, is administered to treat conditions such as nephrogenic diabetes insipidus and lithium-induced nephropathy, as well as to improve concentration ability impaired by lithium treatment. It is also studied as a potential treatment for bipolar disorder and lithium toxicities.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}